Tammy McDaid, a mother from Swansea, has shared her devastating experience after her son, Tate, was diagnosed with Sanfilippo syndrome, a rare form of childhood dementia. Initially, she believed Tate was simply a calm child, as he seldom cried during infancy. However, a routine assessment for autism led to a CT scan that revealed a concerning bump on his head, prompting further investigation.
The diagnosis journey was fraught with uncertainty, lasting 18 months. Despite reassurances from medical professionals that Tate did not have Sanfilippo, Tammy’s instincts told her otherwise. She noticed similarities between her son and other children with the syndrome, which is characterized by distinctive physical features and progressive loss of abilities.
Sanfilippo syndrome affects approximately one in 70,000 births in the UK, leading to severe neurological decline and often resulting in death during the teenage years. Currently, treatment options are limited to pain management, but a new drug awaiting FDA approval could potentially halt the disease’s progression. However, the estimated cost of this treatment could reach up to £3 million, placing immense financial pressure on the family.
Tammy has launched a fundraising campaign to secure the necessary funds for Tate’s treatment. She remains hopeful that the drug will be approved soon, as every moment counts in preventing further deterioration of her son’s condition. “Tate is a spring chicken,” she says, determined to keep his spirit alive as he continues to enjoy life.
Source: GB News
